Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.57 |
| ▸ | MEN1 | O00255 | 6/20 | 0.57 |
| ▸ | CXCR1 | P25024 | 3/20 | 0.57 |
| ▸ | CXCR2 | P25025 | 3/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | PPIA | P62937 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.48 |
| ▸ | KCNMA1 | Q12791 | 2/20 | 0.48 |
| ▸ | PPIF | P30405 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7489143 | 0.87 | PPIA (0.62) | KMT2AMEN1CXCR1CXCR2TDP1 | |
| SCHEMBL7484203 | 0.84 | PPIA (0.59) | KMT2AMEN1CXCR1CXCR2TDP1 | |
| SCHEMBL7486202 | 0.84 | CXCR1 (0.57) | KMT2AMEN1CXCR1CXCR2TDP1 | |
| SCHEMBL5594899 | 0.84 | KMT2A (0.63) | KMT2AMEN1CXCR1CXCR2TDP1 | |
| SCHEMBL7549869 | 0.83 | MEN1 (0.62) | KMT2AMEN1CXCR1CXCR2TDP1 | |
| SCHEMBL3710415 | 0.82 | KMT2A (0.68) | KMT2AMEN1CXCR1CXCR2TDP1 | |
| SCHEMBL6820169 | 0.82 | KMT2A (0.68) | KMT2AMEN1CXCR1CXCR2TDP1 | |
| SCHEMBL7549656 | 0.80 | KMT2A (0.57) | KMT2AMEN1CXCR1CXCR2TDP1 | |
| SCHEMBL7552006 | 0.80 | CXCR2 (0.57) | KMT2ACXCR1CXCR2PPIAMAPT | |
| SCHEMBL6823227 | 0.80 | KMT2A (0.67) | KMT2AMEN1CXCR1CXCR2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020128321-A1 | IL-8 receptor antagonists | SMITHKLINE BEECHAM CORPORATION | 2002-09-12 | — | — | US | disclosed |
| US-6262113-B1 | HYDROXY- OR MERCAPTO-PHENYLUREAS | SMITHKLINE BEECHAM CORPORATION | 2001-07-17 | — | — | US | disclosed |
| US-6211373-B1 | Phenyl urea antagonists of the IL-8 receptor | SMITHKLINE BEECHAM CORPORATION | 2001-04-03 | — | — | US | disclosed |
| US-5780483-A | IL-8 receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 1998-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128321-A1 | IL-8 receptor antagonists | CXCL8, CCR8, IL1RN | KMT2A 3978/4885MEN1 4754/4885CXCR1 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.